What do PET scans do: a clear, patient-friendly guide
Positron emission tomography (PET) is a medical imaging test many patients encounter when doctors are trying to understand disease activity inside the body. Unlike X-rays or standard CT and MRI scans, PET shows metabolic and biochemical processes rather than just anatomy. That capability makes PET a powerful tool for diagnosing, staging, and monitoring conditions such as cancer, heart disease and some brain disorders. This guide explains in patient-friendly language what PET scans do, why clinicians order them, and how the test fits into clinical decision-making. The goal is practical clarity: you should leave knowing what to expect, what the results may tell your care team, and what limitations to keep in mind before a PET scan appointment.
How does a PET scan work and what is a radiotracer?
A PET scan detects tiny amounts of radioactive material called a radiotracer that a technician injects, inhales, or gives by mouth. The most common tracer in clinical practice is fluorodeoxyglucose (FDG), a glucose-like molecule labeled with a radioactive atom. Active cells—such as many cancer cells, inflamed tissue, or metabolically active brain regions—take up more FDG, and the PET scanner records the gamma rays emitted as the tracer decays. Software converts those signals into colorized images that highlight areas of increased or decreased metabolic activity. PET is often combined with CT (a PET/CT) so radiologists can correlate metabolic information with precise anatomy. This functional imaging capability explains why clinicians rely on PET scan uses when structural imaging alone does not answer the clinical question.
What conditions do PET scans detect and how are tracers chosen?
PET scans are used across specialties. In oncology, PET for cancer is central to staging, detecting recurrence, and assessing response to therapy. Neurology uses brain PET scans to evaluate dementia subtypes, seizure foci, and some movement disorders. Cardiology uses cardiac PET scan techniques to evaluate blood flow and viability after heart attacks. Nuclear medicine departments may also use PET to investigate unexplained fevers or suspected infection. Different radiotracers target different processes—FDG highlights glucose metabolism, while other tracers are designed for specific receptors or proteins. Below is a simple table showing common tracers and typical clinical uses:
| Tracer | Primary use | Typical clinical question |
|---|---|---|
| FDG (fluorodeoxyglucose) | General metabolic activity | Cancer staging, infection, inflammation |
| Amyloid tracers (e.g., florbetapir) | Brain amyloid deposition | Support evaluation for Alzheimer’s disease |
| Rubidium-82 / N-13 ammonia | Myocardial perfusion | Assess blood flow and viability in heart disease |
What should you expect during a PET scan appointment?
Preparation often involves fasting for several hours to lower blood glucose, which improves FDG uptake contrast; specific instructions vary by tracer and clinical question. On arrival you’ll be injected with the radiotracer and rest quietly for a waiting period (typically 30–90 minutes) to allow uptake. The scan itself usually takes 20–45 minutes and is painless; you lie on a table that slides through the scanner while cameras rotate around you. A combined PET/CT scan requires staying still during both parts so images align. Afterward, most people can resume normal activities; clinicians sometimes suggest avoiding close contact with pregnant people or infants for a short time due to residual radioactivity. Many patients ask about PET CT scan cost and scheduling—those vary by facility and insurance coverage, so check logistics before your visit.
What are the risks, limitations and alternatives to PET?
PET scan risks are generally low but include exposure to a small amount of ionizing radiation from the radiotracer and CT component. For most adults the dose is comparable to other diagnostic imaging exams and is considered acceptable when the expected diagnostic benefit is significant. Pregnancy is usually a contraindication unless the test is essential; breastfeeding guidance depends on the tracer. PET has limitations: it can produce false positives (for example, inflammation can mimic cancer) and false negatives (small or low-metabolic tumors may not show up). Alternatives or complementary tests include contrast-enhanced CT, MRI, and nuclear SPECT imaging—each provides different information. Discuss PET scan vs CT or MRI with your physician to understand why PET was chosen for your situation.
How are PET scan results reported and used to guide care?
Radiologists provide a report describing areas of abnormal tracer uptake, often using standardized measures such as SUV (standardized uptake value) to quantify activity. The report interprets findings in the context of your symptoms, prior imaging, and clinical history; it typically avoids definitive statements without correlation to biopsy or further tests. For suspected cancer, PET results can change staging, guide biopsy locations, or influence whether a surgeon, oncologist, or radiation oncologist will recommend different treatments. In neurology or cardiology, PET findings are part of a broader assessment that includes clinical testing and other imaging. If your report raises questions, ask your referring physician to walk through the images and explain potential next steps, which may include monitoring, targeted biopsy, or therapy adjustments.
How to prepare mentally and practically for a PET scan and what it means for you
Knowing what a PET scan does can reduce anxiety and help you participate in your care. Practical tips: follow fasting and medication instructions, wear comfortable clothing without metal, and arrange for any necessary transportation if your medical team recommends it. Bring a list of current medications and prior imaging or reports if available. Understanding that PET provides metabolic information—not a standalone diagnosis—sets realistic expectations: it’s powerful when combined with clinical judgment, pathology, and other tests. If cost or access is a concern, your care team or insurance navigator can explain coverage and potential alternatives. Ask for a clear explanation of how the PET results will influence the next steps in your care.
Medical disclaimer: This article provides general information about PET scans and is not medical advice. For personalized recommendations, scheduling, or interpretation of test results, consult your physician or a qualified imaging specialist.
This text was generated using a large language model, and select text has been reviewed and moderated for purposes such as readability.
